We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Evotec Logo

Evotec

Evotec are a R&D biotech that offers accelerating, high value pipeline co-creation partnerships and comprehensive CRO/CDMO services – always striving for highest quality, capital efficient execution of R&D programs from disease understanding towards IND, Phase 1, and beyond. Our expertise spans across therapeutic/disease areas and most modalities, especially small molecules and biotherapeutics. We take pride in acting as "drug hunters" in deep collaboration with our partners to advance science. At the core of our operations are our industrialized, AI-powered proprietary R&D platforms, including PanOmics and iPSC technologies. These platforms are instrumental in enhancing disease understanding and ensuring human relevance in our research. By integrating AI and continuous manufacturing technology, we facilitate better access to high-quality biotherapeutics, revolutionizing the way treatments are developed and produced.

Latest Content

Cover and open page of an eBook focused on proteomics tools, techniques and research. Text reads: Proteomics: Tools, Techniques and Translational Potentia
eBook

Proteomics: Tools, Techniques and Translational Potential

Proteomics continues to evolve rapidly, offering powerful tools to unravel complex biological systems. This eBook explores key methodologies and innovations reshaping proteomics, from foundational techniques to AI-enhanced data analysis.
Two scientists in lab coats reviewing drug discovery data on a tablet and laptop in a research laboratory.
Product News

Evotec Announces Significant Progress in Strategic Protein Degradation Collaboration With Bristol Myers Squibb

Evotec and Bristol Myers Squibb's collaboration reaches new milestones, advancing their molecular glue-based pipeline with $75 million in payments.
A capsule pill floating amid molecular structures and a DNA helix, symbolizing drug discovery and pharmaceutical innovation.
eBook

Drug Discovery: Innovations, Challenges and the Future of Medicine

This eBook explores the latest advancements in drug discovery, from AI-driven precision medicine to the promise and risks of new weight loss drugs.
A purple brain.
Product News

Evotec Announces Key Progress in Neuroscience Collaboration With Bristol Myers Squibb

Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) announced another major accomplishment in its long-standing neuroscience collaboration with Bristol Myers Squibb (NYSE: BMY).
Scientist wearing a lab coat, hairnet, face mask and gloves working in a bioprocessing facility.
Article

The Promise of Continuous Processing To Advance Biopharmaceutical Production

This article explores how switching to an automated continuous manufacturing process can improve product yields and quality, lower capital expenditures, reduce facility footprints and minimize waste, ultimately reducing the price tag of biologics.
Digital rendering of glowing cells and biomolecules
Online Event

Innovations in Biopharma 2025

On-Demand
New for 2025, this event will provide insights from both big pharma and emerging biotech firms. Attendees will gain a comprehensive understanding of how rapid technological advancements are reshaping therapeutic development and delivery.
Antibodies.
Product News

Evotec Receives Grant From Korean Government To Develop Novel Antibody-Based Treatments for Lung Diseases

Evotec SE announced that, together with Yonsei University and the Korean biotech company Zymedi, it will receive a US$ 4.5m grant from the Korea Institute of Advanced Technology (KIAT).
Three researchers in a lab.
Product News

Evotec SE Announces First Projects for LAB eN² Drug Discovery Accelerator With Novo Nordisk

Novo Nordisk and Evotec select three projects from Boston University, Harvard University in collaboration with Mass General Brigham, and Joslin Diabetes Center to be developed within LAB eN² focusing on cardiometabolic diseases.
A snippet of spatial transcriptomics in neuroscience infographic on a dark navy background.
Infographic

Spatial Transcriptomics in Neuroscience

Single-cell RNA sequencing (scRNA-seq) approaches can provide transcriptomic profiles of individual cells isolated from brain tissue.
Transparent molecular structure representation illustrating concepts in harnessing structural insights for drug discovery.
Webinar

Harnessing Structural Insights in Drug Discovery

On-Demand
This webinar explores how structural biology drives success in drug discovery projects.
Advertisement